Canine Oral Melanoma Treatment
RecruitingA fully funded trial to treat canine oral melanoma using a brand new drug over the course of 6 months.
Processing...
Connect directly with leading university research for canine and feline cancer trials.
A fully funded trial to treat canine oral melanoma using a brand new drug over the course of 6 months.
A fully funded trial lasting 4 months to treat oral squamous cell carcinoma in dogs using a small molecule inhibitor currently used in human cancer treatment.
A trial combining standard of care with a novel vaccine to treat hemangiosarcoma over the course of a year.
A fully funded trial lasting 3 months to test a new oral drug designed to treat canine lymphoma at home.
An exciting fully funded trial to treat metastatic lung cancer combining radiation with a new monoclonal antibody.
A fully funded trial for cats with metastatic mammary carcinoma using a novel therapeutic agent.
A brand new funded treatment for canine lymphoma combining a novel virus with a checkpoint inhibitor.
A mostly funded trial for canine osteosarcoma combining amputation with a vaccine-enhanced adoptive T-cell therapy.
An exciting fully funded trial testing a new treatment for canine lymphoma using cutting edge CAR-T cell therapy.
A month long funded trial to treat oral tumors in cats using a vaccine to stimulate the animal's own anti-tumor immune response.
A fully funded trial to treat canine soft tissue sarcoma using a novel antibody that stimulates the body's own immune system.
A fully funded trial to treat dogs with hepatocellular carcinoma when surgical removal is not possible using transarterial embolization with or without chemotherapy.
A novel new drug enitociclib is used in a fully funded trial to treat bladder cancer in dogs.
A fully funded trial for canine splenic hemangiosarcoma by adding an oral small molecule inhibitor to the standard of care chemotherapy.
A fully funded trial for the treatment of osteosarcoma using a combined autologous vaccine with a novel checkpoint inhibitor.
We only feature active trials from accredited universities nationwide.
Finding a leading university-led clinical trial for your dog or cat with cancer can be complex. We simplify the entire process, connecting you directly with the research teams seeking patients right now.
Our streamlined four-step process ensures a fast, accurate, and confidential referral:
The process begins with you. You'll complete our secure, quick-to-fill online profile, providing essential information about your pet. This includes their specific cancer diagnosis (e.g., type, stage, and previous treatments), age, weight, and general health status.
This data is the foundation for finding the most accurate matches.
Once submitted, our powerful system instantly compares your pet's profile against the eligibility requirements of every current, open clinical trial in our database. Since we only feature trials from reputable universities, you can trust the criteria are precise and up-to-date.
We focus only on matching you to trials your pet is genuinely eligible for.
If one or more strong matches are identified, you choose which (if any) you would like to be considered for. We immediately generate a confidential referral. Your pet's relevant medical details and your contact information are securely forwarded to the Veterinary Clinical Research team at the corresponding university or trial site.
We handle the introduction; the research team takes over from here.
A member of the university's research team will contact you directly. They will personally review the case with you, answer any questions you have about the protocol, and discuss the financial and logistical details. Final enrollment only proceeds if your pet remains a good candidate, and you provide your full, informed consent.
You are in control. Enrollment is always voluntary and requires your approval.
Clinical trials offer unique benefits for pets with cancer and their families.




Loading reviews...